Neuraxis (NRXS) Earnings Date & Reports

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRXS is expected to report earnings to fall 34.78% to -15 cents per share on April 09

Q4'23

Est.

$-0.15

Q4'24

Missed

by $0.27

Q1'24

Missed

by $0.22

Q3'23

Missed

by $1.18

The last earnings report on March 20 showed earnings per share of -23 cents, missing the estimate of 3 cents. With 69.03K shares outstanding, the current market capitalization sits at 14.07M.

View a ticker or compare two or three

Compare

NRXS